ClinicalTrials.gov
ClinicalTrials.gov Menu

MapTrek for Sedentary Workers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03109535
Recruitment Status : Completed
First Posted : April 12, 2017
Last Update Posted : April 28, 2017
Sponsor:
Information provided by (Responsible Party):
Lucas Carr, University of Iowa

Brief Summary:
The aim of this study is to determine if participants randomized to our mHealth MapTrek game increases daily physical activity (average steps/day, active minutes/day) compared to a control group among sedentary office workers over 10 weeks. The investigators hypothesize the MapTrek intervention group will significantly increase their daily steps and active minutes compared to the control group over 10 weeks.

Condition or disease Intervention/treatment Phase
Sedentary Lifestyle Behavioral: Fitbit + Maptrek Behavioral: Fitbit only Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 146 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: MapTrek for Sedentary Workers
Actual Study Start Date : September 1, 2016
Actual Primary Completion Date : December 15, 2016
Actual Study Completion Date : April 1, 2017

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Fitbit-only Group
Participants received a Fitbit Zip activity monitor to wear daily for 10 weeks.
Behavioral: Fitbit only
Users receive a Fitbit Zip to wear daily.

Experimental: Fitbit + MapTrek Group
Participants received a Fitbit Zip activity monitor to wear daily for 10 weeks. Participants also received access to an mHealth game called MapTrek for 10 weeks. MapTrek places users in weekly walking races and sends automated text messages to participants on a daily basis. Messages include a link to the online game as well as motivational messages designed to increase physical activity.
Behavioral: Fitbit + Maptrek
Users receive a Fitbit Zip to wear daily. Users aslo receive the mHealth MapTrek game that places users in weekly walking races and sends automated text messages to users on a daily basis for the purpose of increasing daily physical activity.




Primary Outcome Measures :
  1. Average daily steps [ Time Frame: 10 weeks ]
    Total daily steps as recorded by the Fitbit Zip


Secondary Outcome Measures :
  1. Average daily active minutes [ Time Frame: 10 weeks ]
    Minutes with at least 100 steps/minute as recorded by the Fitbit Zip



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Eligible participants were 21 to 65 year of age, working full-time (at least 35 hours/week) in a desk-dependent job (self-report sitting >75% of work day), who owned a smart phone.

Exclusion Criteria:

  • Exclusion criteria included ages <18 years or >65 years, pregnancy or planned pregnancy, prisoner status, and any contraindications to engaging in regular physical activity as identified by the Physical Activity Readiness Questionnaire (PAR-Q), not owning a smart phone, (Cardinal, Esters, & Cardinal, 1996).

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Lucas Carr, Assistant Professor, University of Iowa
ClinicalTrials.gov Identifier: NCT03109535     History of Changes
Other Study ID Numbers: 201608733
First Posted: April 12, 2017    Key Record Dates
Last Update Posted: April 28, 2017
Last Verified: April 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No